Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013 (2013), Article ID 671848, 4 pages
Case Report

Laparoscopic Adjustable Gastric Banding and Hypoglycemia

1Department of Surgery, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA
2Department of Surgery, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
3Pediatric Surgical Associates, Children's Hospitals and Clinics of Minnesota, Minneapolis, MN 55404, USA
4Department of Surgery, Emerson Hospital-Mass General Hospital, Harvard Medical School, 133 Old Road to Nine Acre Corner, Concord, MA 01742, USA

Received 2 August 2013; Accepted 17 September 2013

Academic Editors: H. Kang and X. Zhang

Copyright © 2013 Sigrid Bairdain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Obesity is commonplace, and surgical treatment usually includes Roux-en-Y gastric bypasses (RYGBs). RYGBs have the most documented side effects including vitamin deficiencies, rebound weight gain, and symptomatic hypoglycemia; fewer series exist describing hypoglycemia following other bariatric operations. We reviewed all patients undergoing laparoscopic adjustable gastric banding (LAGB) at our institution between 2008 and 2012. Three patients were identified to have symptomatic hypoglycemia following LAGB. Mean time from surgery was 33 months (range 14–45 months), and mean weight loss was 32.7 kg (range 15.9–43.1 kg). None of the patients had preexisting diabetes. Therefore, symptomatic hypoglycemia should be investigated irrespective of bariatric operation.